Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BRC | ERO |
|---|---|---|
| Price | $85.41 | $38.44 |
| Change today | ▲ 0.74% | ▲ 1.40% |
| Market cap | $4.01B | $4.01B |
| Return, 3 months | -6.4% | +54.4% |
| Return, year to date | +9.9% | +35.9% |
| Return, 1 year | +14.0% | +77.6% |
| P/E (TTM) | 19.9 | 13.0 |
| P/B | 3.0 | 3.3 |
| P/E percentile vs own 5y | 83rd | – |
| Dividend yield | 1.15% | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | -4.4% |
| Analyst buy share | – | 45% |
| RSI (14) | 45 | 59 |
| 30-day volatility | 19.5% | 61.0% |
| Max drawdown, 1 year | -26.1% | -38.0% |
| Trend read | Leaning bullish | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.